SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-128122
Filing Date
2023-05-01
Accepted
2023-04-28 20:30:00
Documents
13
Period of Report
2023-04-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d491486d8k.htm   iXBRL 8-K 27132
2 EX-99.1 d491486dex991.htm EX-99.1 10198
  Complete submission text file 0001193125-23-128122.txt   164361

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA inva-20230428.xsd EX-101.SCH 2841
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20230428_lab.xml EX-101.LAB 18018
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20230428_pre.xml EX-101.PRE 11261
7 EXTRACTED XBRL INSTANCE DOCUMENT d491486d8k_htm.xml XML 3410
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 23869515
SIC: 2834 Pharmaceutical Preparations